Patrick R. O'Neil

Patrick R. O'Neil is a declared insider of Ionis Pharmaceuticals Inc (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 1 January 2016 to 26 June 2026, the count stands at 48 filings.

Sales make up the whole of the open-market record (16 sales, €1.8M). No amount is published for 8 filings, which the totals therefore leave out. Other entries cover 4 share grants and 19 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

The newest entry dates from 30 June 2026: an open-market sale, in Ionis Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.